Macrophages

28,096 views 55 slides Jun 27, 2018
Slide 1
Slide 1 of 55
Slide 1
1
Slide 2
2
Slide 3
3
Slide 4
4
Slide 5
5
Slide 6
6
Slide 7
7
Slide 8
8
Slide 9
9
Slide 10
10
Slide 11
11
Slide 12
12
Slide 13
13
Slide 14
14
Slide 15
15
Slide 16
16
Slide 17
17
Slide 18
18
Slide 19
19
Slide 20
20
Slide 21
21
Slide 22
22
Slide 23
23
Slide 24
24
Slide 25
25
Slide 26
26
Slide 27
27
Slide 28
28
Slide 29
29
Slide 30
30
Slide 31
31
Slide 32
32
Slide 33
33
Slide 34
34
Slide 35
35
Slide 36
36
Slide 37
37
Slide 38
38
Slide 39
39
Slide 40
40
Slide 41
41
Slide 42
42
Slide 43
43
Slide 44
44
Slide 45
45
Slide 46
46
Slide 47
47
Slide 48
48
Slide 49
49
Slide 50
50
Slide 51
51
Slide 52
52
Slide 53
53
Slide 54
54
Slide 55
55

About This Presentation

activity markers, activation pathways, antimicrobial mechanisms of macrophages.


Slide Content

Activation markers, Activation pathways ,Antimicrobial mechanisms of Macrophages Dr.N.N.Jyothi Junior resident

Introduction Macrophage activation pathways Antimicrobial mechanisms of Macrophages

Definition: Macrophages are tissue cells derived from BONE MARROW  HEMATOPOIETIC STEM CELL YOLK SAC FETAL LIVER ( devolpmental stages ) The half­life of blood monocytes is about 1 day tissue macrophages is several months or years,

Specific location Type Circulation Monocytes Liver Kupffer cells Spleen, Lymph nodes Sinus histiocytes CNS Microglia Lungs Alveolar macrophages Skin Langerhans cells/dendritic cells

Kupffer cells NORMAL MALARIA

MICROGLIA

HISTIOCYTES REACTIVE HYPERPLASIA SINUS HISTIOCYTES

EMPERIPOLESIS KIKUCHI-FUJIMOTO

Alveolar macrophages Macrophage found in the pulmonary alveolus, near the pneumocytes , but separated from the wall.

FUNCTIONS OF MACROPHAGES Ingest and eliminate microbes and dead tissues .(phagocytosis) Initiate the process of tissue repair . Secrete mediators of inflammation, central to the initiation and propagation of inflammatory reactions .   Macrophage-lymphocyte interactions

Activation pathways

Classic activation Exposure to IFN-G, TLR agonist (microbial products) Activation of macrophages Expression of MHC, CD80/86. APCs

IFN-G Induces production of iNOS , ROS , proteolytic enzymes. Phagosome maturation.

Alternative activation T cell  Th2 phenotype Production of IL-4 & IL-13 . Cytokines  alternatively activate macrophages &enhance endocytosis , Increased MHC classII expression. The production of arginase may compete for substrate with iNOS . Reduces the capacity of these cells to kill intracellular pathogens

Promote healing of inflammatory reactions, and the induction of humoral responses . Fibrogenic cytokines Angiogenesis Remodelling collagenesis ….

Phagocytosis Capability of ingesting and destroying invading organisms.(intracellularly) Recognition and attachment of the particle to be ingested by the leukocyte. Engulfment  phagocytic vacuole . Killing or degradation of the ingested material.

Recognition and attachment Pathogen associated molecules PAM (such as surface carbohydrates, peptidoglycans or lipoproteins) Pattern recognition receptors PRR , ex:- TLR Opsonins

Opsonization The process in which certain antibodies ( IgGantibodies &C3b ) in the blood (known as  opsonins ) bind to the surface of an invading microorganism, which renders it more susceptible to phagocytosis

Opsonins recognized by phagocytic receptors, such as Fcγ receptors ( FcγRs ) and complement receptor 3 (CR3 ). BRUTON’S DISEASE : X-linked agammaglobulinemia (XLA) Defect in the maturation of B-cells Absence of immunoglobulins (Ig) Defective opsonization

Recognition : Phagocyte receptors : Fc mediated receptors Complement mediated Receptors Mannose receptors Scavenger receptors Induce rearrangements in the actin cytoskeleton that lead to the internalization of the particle

Fc Receptor-Mediated Phagocytosis

Fc Receptor-Mediated Phagocytosis

Complement Receptor-Mediated Phagocytosis CR1, CR3, and CR4 are expressed on macrophages. Particle ingestion by CRs can be induced by PKC activators  PMA, TNF-α , (GM-CSF).

Differences: Pseudopodia protrude from the macrophage surface to engulf the IgG-opsonized particle, complement-coated particle sinks directly into the cell . FcR ( ROS,AAM) pro-inflammatory molecules

Mannose Receptor-Mediated Phagocytosis Recognizes mannose & fucose on the surfaces of pathogens and mediates phagocytosis of the organisms Pro-inflammatory process IL-1β, IL-6, GM-CSF, TNF-α & IL-12

SCAVENGER RECEPTORS Wide variety of microbes. Modified LDL particles . The Kupffer cells in the liver are particularly rich in  scavenger receptors . Atherosclerosis  endocytose the modified Lipoproteins (FOAM CELL)

PHAGOLYSOSOME

Effective phagocytosis therefore requires two components: Particle internalization. Phagosomal maturation

ENGULFMENT The plasma membrane pinches off to form a vesicle (phagosome) that encloses the particle. The phagosome then fuses with a lysosomal granule, resulting in discharge of the granule’s contents into the phagolysosome

P hagosomal maturation

Microbicidal activity of the phagosome Acidification of phagosome (V- ATPases ) ROS & (NO ), Lysosomal enzymes ( antimicrobial proteins & peptides ) Respiratory burst   is the rapid release of  reactive oxygen species  ( superoxide radical  and  hydrogen peroxide ).

ROS O2  REACTIVE OXYGEN SPECIES H2O2OCl2- ( Myelo Peroxidase Enzyme). H2O2-MPO-halide system is an effective bactericidal system.

MPO deficiency  increased susceptibility to infection. Hereditary MPO deficiency  autosomal recessive pattern. acquired myeloperoxidase deficiency. Pregnancy Lead intoxication  - Inhibits heme synthesis (a component of mature MPO) Iron deficiency Severe infection - Secondary to PMN activation and "consumption" of MPO Thrombotic diseases Renal transplantation Diabetes mellitus Hematological disorders

NITRIC OXIDE Arginine ------------NO Enos / Nnos / Inos iNOS , the type that is involved in microbial killing. NOS

Role in tuberculosis

TH1 response After 3 weeks of infection Mycobacterial antigens displayed to T-cells by APC. TH1 differentiation (IL-12) TUBERCULIN POSITIVITY.

TH1 mediated macrophage actiation TH1  IFN-g macrophage activation TNF release monocyte recruitment Ex: TNF antagonist (RA)  increased of TB reactivation.

M.tuberculosis Arrest in phagosome maturation

L .pneumophilia Failure to form phagolysosome Promotes fusion with ER-derived vesicles.

L.monocytogenes Secretes ListeriolysinO (LLO) Escapes the phagosome

C.burnetii Delays phagosome maturation Undergoes replication in it.

Leukocyte-Mediated Tissue Injury Normal defense reaction against infectious microbes, when adjacent tissues suffer collateral damage. Inappropriately directed inflammatory response against host tissues  autoimmune diseases. Host reacts excessively  as in allergic diseases (asthma).

Phagocyte defects Chronic granulomatous disease of childhood (CGD), Chediak -Higashi syndrome (CHS) , Hyper immunoglobulin-E -recurrent infection (Job's) syndrome (HIE ) . Myeloperoxidase ( MPO) deficiency.

Phagocyte defect inheritence defect 1 Chronic granulomatous disease (PIDD) X-linked/Autosomal recessive Hydrogen peroxide 2 Chediak higashi syndrome LYST GENE MUTATION Autosomal recessive LYST  gene mutation Non functional lysosomes 3 Job's syndrome (HIE) . STAT3 GENE MUTATION Autosomal dominant  or autosomal recessive. High concentrations of the serum IgE . 4 MPO DEFICIENCY Hereditary/acquired Mpo deficiency

CGD  defective oxidative metabolism involved in killing catalase-positive organisms. CHS  giant granules defective in fusing with phagosomes and subsequent killing of ingested organisms. HIE  abnormal chemotaxis and elevated IgE levels and are susceptible to skin infections with Staphylococcus aureus and recurrent sinopulmonary infections.

4. MPO-deficiency  go undetected since they rarely have recurrent infections unless they have a concomitant disease such as diabetes mellitus.

Macrophage-Lymphocyte interaction

References Kumar, V., Abbas, A. K., Fausto, N., Robbins, S. L., & Cotran , R. S.   Robbins and Cotran pathologic basis of disease . Philadelphia: Elsevier Saunders . Inflammation & repair pg no 88-104. White CJ, Gallin JI. Phagocyte defects.  Clin Immunol Immunopathol .  1986;40:50–61 Aderem A, Underhill DM. Mechanisms of phagocytosis in macrophages. Annual Review of Immunology. 1999;17:593–623. de Villiers WJ, Smart EJ. Macrophage scavenger receptors and foam cell formation. J Leukoc Biol.  1999;66:740–6 Gordon, Siamon & O Martinez, Fernando. (2010). Alternative Activation of Macrophages: Mechanism and Functions. Immunity. 32. 593-604. R.S.  Flannagan , G.  Cosío , S.  Grinstein Antimicrobial mechanisms of phagocytes and bacterial evasion strategies Nat . Rev. Microbiol ., 7 (2009), pp. 355-366
Tags